Antitumor Activity of PEGylated Nanoliposomes Containing Crocin in Mice Bearing C26 Colon Carcinoma

Abstract

Crocin is a pharmacologically active component of Crocus sativus. It is an unusual water-soluble carotenoid responsible for the red color of saffron. In various studies, the anticancer effect of saffron and its constituents has been established. Polyethylene glycolated nanoliposomes with a size range up to 200 nm are suitable for encapsulation of cytotoxic drugs and can target tumors passively through the enhanced permeation and retention effect. The aim of this study was to develop a nanoliposomal formulation containing crocin with a higher therapeutic index for the treatment of cancer. Four formulations of polyethylene glycolated nanoliposomes containing 25 mg/ml crocin were prepared with hydrogenated soy phosphatidylcholine, cholesterol, and methoxy-polyethylene glycol (MW 2000)-distearoylphosphatidylcholine at different molar ratios by a solvent evaporation method plus extrusion. Then the liposomes were characterized for their size, zeta potential, crocin encapsulation, release properties, and in vitro cytotoxicity against C26 colon carcinoma cells. Based on in vitro results, the best formulation was selected for an in vivo study, and its antitumor activity was evaluated in BALB/c mice bearing C26 colon carcinoma. The IC₅₀ of crocin itself against C26 colon carcinoma was 0.73 mM. The characterization of the best formulation was as follow: Z-average size: 127.6 ± 1.5 nm; polydispersity index: 0.087 ± 0.018; zeta potential: − 21.7 mV ± 6.7; % encapsulation: 84.62 ± 0.59; % release after 168 hours in RPMI 1640 containing 30 % FBS: 16.26 ± 0.01 %. Liposomal crocin at doses of 50 and 100 mg/kg significantly decreased tumor size and increased survival rate compared with PBS and crocin in buffer (100 mg/kg) groups. The results of this study indicated that liposomal encapsulation of crocin could increase its antitumorigenic activity. Thus, to obtain an optimal dose for use in humans, the formulation merits further investigation.

Key words

Crocus sativus - Iridaceae - saffron - crocin - PEGylated nanoliposome - antitumor activity - cancer - C26 colon carcinoma

• References

• 1 Gutheil W, Reed G, Ray A, Anant S, Dhar A. Crocetin: an agent derived from saffron for prevention and therapy for cancer. Curr Pharm Biotechnol 2012; 13: 173-179
• 2 Abdullaev FI. Biological effects of saffron. Biofactors 1993; 4: 83-86
• 3 Abdullaev FI. Cancer chemopreventive and tumoricidal properties of saffron (Crocus sativus L.). Exp Biol Med 2002; 227: 20-25
• 4 Behravan J, Hosseinzadeh H, Rastgoo A, Hessani M. Evaluation of the cytotoxic activity of crocin and safranal using potato disc and brine shrimp assays. Physiol Pharmacol 2010; 13: 397-403
• 5 Escribano J, Alonso GL, Coca-Prados M, Fernández JA. Crocin, safranal and picrocrocin from saffron (Crocus sativus L.) inhibit the growth of human cancer cells in vitro . Cancer Lett 1996; 100: 23-30
• 6 Garc-Olmo DC, Riese HH, Escribano J, Onta J, Fernandez JA, Atiénzar M, Garcí-Olmo D. Effects of long-term treatment of colon adenocarcinoma with crocin, a carotenoid from saffron (Crocus sativus L.): an experimental study in the rat. Nutr Cancer 1999; 35: 120-126
• 7 Torchilin VP. Recent advances with liposomes as pharmaceutical carriers. Nat Rev Drug Discov 2005; 4: 145-160
• 8 Maeda H, Wu J, Sawa T, Matsumura Y, Hori K. Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review. J Control Release 2000; 65: 271-284
• 9 Hadizadeh F, Mohajeri S, Seifi M. Extraction and purification of crocin from saffron stigmas employing a simple and efficient crystallization method. Pakistan J Biol Sci 2010; 13: 691-698
• 10 Malaekeh-Nikouei B, Jaafari MR, Tabassi SAS, Samiei A. The enhancement of immunosuppressive effects of cyclosporine A on human T-cells using fusogenic liposomes. Colloids Surf B Biointerfaces 2008; 67: 238-244
• 11 Huang Z, Jaafari MR, Szoka Jr. FC. Disterolphospholipids: nonexchangeable lipids and their application to liposomal drug delivery. Angew Chem Int Ed Engl 2009; 121: 4210-4213
• 12 Baselga J, Norton L, Albanell J, Kim YM, Mendelsohn J. Recombinant humanized anti-HER2 antibody (Herceptin™) enhances the antitumor activity of paclitaxel and doxorubicin against HER2/neu overexpressing human breast cancer xenografts. Cancer Res 1998; 58: 2825
• 13 Nair SC, Pannikar B, Panikkar KR. Antitumour activity of saffron (Crocus sativus). Cancer Lett 1991; 57: 109-114
• 14 Nair SC, Kurumboor SK, Hasegawa JH. Saffron chemoprevention in biology and medicine: a review. Cancer Biother 1995; 10: 257-264
• 15 Smith T. Carotenoids and cancer: prevention and potential therapy. Br J Biomed Sci 1998; 55: 268
• 16 Escribano J, Ríos I, Fernández JA. Isolation and cytotoxic properties of a novel glycoconjugate from corms of saffron plant (Crocus sativus L.). BBA General Subjects 1999; 1426: 217-222
• 17 Tavakkol-Afshari J, Brook A, Mousavi SH. Study of cytotoxic and apoptogenic properties of saffron extract in human cancer cell lines. Food Chem Toxicol 2008; 46: 3443-3447
• 18 Mousavi SH, Moallem SA, Mehri S, Shahsavand S, Nassirli H, Malaekeh-Nikouei B. Improvement of cytotoxic and apoptogenic properties of crocin in cancer cell lines by its nanoliposomal form. Pharm Biol 2011; 49: 1039-1045
• 19 Hatakeyama H, Akita H, Harashima H. A multifunctional envelope type nano device (MEND) for gene delivery to tumours based on the EPR effect: a strategy for overcoming the PEG dilemma. Adv Drug Deliv Rev 2011; 63: 152-160
• 20 Drummond DC, Noble CO, Hayes ME, Park JW, Kirpotin DB. Pharmacokinetics and in vivo drug release rates in liposomal nanocarrier development. J Pharm Sci 2008; 97: 4696-4740
• 21 Papahadjopoulos D, Nir S, Ohki S. Permeability properties of phospholipid membranes: effect of cholesterol and temperature. BBA Biomembranes 1972; 266: 561-583
• 22 Abdullaev F, Espinosa-Aguirre J. Biomedical properties of saffron and its potential use in cancer therapy and chemoprevention trials. Cancer Detect Prev 2004; 28: 426-432
• 23 Premkumar K, Thirunavukkarasu C, Abraham S, Santhiya S, Ramesh A. Protective effect of saffron (Crocus sativus L.) aqueous extract against genetic damage induced by anti-tumor agents in mice. Hum Exp Toxicol 2006; 25: 79-84
• 24 Nair S, Salomi M, Varghese C, Panikkar B, Panikkar K. Effect of saffron on thymocyte proliferation, intracellular glutathione levels and its antitumor activity. BioFactors (Oxford, England) 1992; 4: 51
• 25 Raina BL, Agarwal SG, Bhatia AK, Gaur GS. Changes in pigments and volatiles of saffron (Crocus sativus L.) during processing and storage. J Sci Food Agric 1996; 71: 27-32
• 26 Selim K, Tsimidou M, Biliaderis C. Kinetic studies of degradation of saffron carotenoids encapsulated in amorphous polymer matrices. Food Chem 2000; 71: 199-206
• 27 Hosseinzadeh H, Shariaty VM, Sameni AK, Vahabzadeh M. Acute ad sub-acute toxicity of crocin, a constituent of Crocus sativus L. (saffron), in mice and rats. Pharmacologyonline 2010; 2: 943-951
• 28 Paola P. Carotenoids and modulation of cancer: molecular targets. Curr Pharmacogen 2004; 2: 35-45
• 29 Melnyk JP, Wang S, Marcone MF. Chemical and biological properties of the worldʼs most expensive spice: Saffron. Food Res Int 2010; 43: 1981-1989
• 30 Aung HH, Wang CZ, Ni M, Fishbein A, Mehendale SR, Xie JT, Shoyama CY, Yuan CS. Crocin from Crocus sativus possesses significant anti-proliferation effects on human colorectal cancer cells. Exp Oncol 2007; 29: 175-180